{
  "spec_version": "4",
  "endpoint": "financials-segment",
  "stock_code": "4521",
  "company_name": "科研製薬",
  "content_lang": "ja",
  "meta_lang": "en",
  "canonical_url": "https://the-shashi.com/tse/4521/current/#revenue-mix",
  "api_url": "/api/4521/financials/segment.json",
  "updated": "2026-09-19",
  "license": "© 2026 Yutaka Sugiura. All rights reserved.",
  "attribution": "The社史 (the-shashi.com) — https://the-shashi.com/tse/4521/current/#revenue-mix",
  "source": {
    "segment": {
      "primary": [
        "有価証券報告書（セグメント情報）"
      ],
      "extraction": "EDINET の XBRL から機械抽出",
      "caveat": "セグメント区分は各期の開示区分をそのまま採録しており、期をまたいだ区分の連続性は保証しない"
    },
    "region": {
      "primary": [
        "有価証券報告書（所在地別・海外売上高）"
      ],
      "extraction": "EDINET の XBRL から機械抽出",
      "caveat": "地域区分は各期の開示区分をそのまま採録している"
    }
  },
  "html_url": "https://the-shashi.com/tse/4521/current/#revenue-mix",
  "segment": [
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "不動産事業",
      "sales": 2338,
      "profit": 1513,
      "assets": 11057
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "薬業",
      "sales": 107391,
      "profit": 33633,
      "assets": 75248
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "不動産事業",
      "sales": 2386,
      "profit": 1629,
      "assets": 10815
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "薬業",
      "sales": 99093,
      "profit": 29078,
      "assets": 76876
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "不動産事業",
      "sales": 2407,
      "profit": 1655,
      "assets": 10554
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "薬業",
      "sales": 96022,
      "profit": 25840,
      "assets": 85397
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "不動産事業",
      "sales": 2360,
      "profit": 1476,
      "assets": 10277
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "薬業",
      "sales": 91804,
      "profit": 23116,
      "assets": 81908
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "不動産事業",
      "sales": 2378,
      "profit": 1463,
      "assets": 10024
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "薬業",
      "sales": 86853,
      "profit": 25048,
      "assets": 69597
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "不動産事業",
      "sales": 2365,
      "profit": 1418,
      "assets": 10207
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "薬業",
      "sales": 72614,
      "profit": 16370,
      "assets": 71658
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "不動産事業",
      "sales": 2410,
      "profit": 1353,
      "assets": 10393
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "薬業",
      "sales": 73623,
      "profit": 15710,
      "assets": 75581
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "不動産事業",
      "sales": 2422,
      "profit": 1290,
      "assets": 10090
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "薬業",
      "sales": 70562,
      "profit": 6707,
      "assets": 74223
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "不動産事業",
      "sales": 2430,
      "profit": 1373,
      "assets": 9777
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "薬業",
      "sales": 69613,
      "profit": 8140,
      "assets": 86015
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "不動産事業",
      "sales": 2481,
      "profit": 1375,
      "assets": 11285
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "薬業",
      "sales": 91553,
      "profit": 19659,
      "assets": 100220
    }
  ],
  "region": [
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 67426
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "北米",
      "sales": 4133
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "欧州",
      "sales": 18148
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アジア",
      "sales": 3808
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 518
    }
  ]
}